Early treatment-induced improvement of negative symptoms predicts cognitive functioning in treatment-naïve first episode schizophrenia: A 2-year followup

Schizophrenia Bulletin

Volumn 30, Issue 4, 2004, Pages 837-848

  Schuepbach, Daniel ^a   Hill, S Kristian ^b   Sanders, Richard D ^c   Hell, Daniel ^a,d   Keshavan, Matcheri S ^e   Sweeney, John A ^f  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VA Pittsburgh Healthcare System ^*  (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Followup; Learning; Neuropsychology; Schizophrenia; Verbal memory

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; HALOPERIDOL; LOXAPINE; NEUROLEPTIC AGENT; PERPHENAZINE; RISPERIDONE;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; DEMOGRAPHY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LEARNING; MALE; MEMORY; NEGATIVE SYNDROME; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; VERBAL BEHAVIOR;

EID: 16344377266     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a007136     Document Type: Article

References (46)

1. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: APA, 1994.
2. Andreasen, N.C. The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and theoretical foundations. British Journal of Psychiatry, 155(Suppl 7):49-58, 1989.
3. Andreasen, N.C. Methods for assessing positive and negative symptoms. Modern Problems of Pharmacopsychiatry, 24:73-88, 1990.
4. Benton, A.L. Visual perception of line direction in patients with unilateral brain disease. Neurology, 25:907-910, 1975.
5. Benton, A.L., and Hamsher, K. Multilingual Aphasia Examination. Iowa City, IA: AJA Associates, 1983.
6. Bilder, R.M.; Goldman, R.S.; Robinson, D.; Reiter, G.; Bell, L.; Bates, J.A.; Pappadopulos, E.; Willson, D.F.; Alvir, J.M.J.; Woerner, M.G.; Geisler, S.; Kane, J.M.; and Lieberman, J.A. Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates. American Journal of Psychiatry, 157:549-559, 2000.
7. Bilder, R.M.; Lipschutz-Broch, L.; Reiter, G.; Geisler, S.; Mayerhoff, D.; and Lieberman, J.A. Neuropsychological deficits in the early course of first-episode schizophrenia. Schizophrenia Research, 5:198-199, 1991.
8. Bilder, R.M.; Lipschutz-Broch, L.; Reiter, G.; Geisler, S.H.; Mayerhoff, D.I.; and Lieberman, J.A. Intellectual deficits in first-episode schizophrenia: Evidence for progressive deterioration. Schizophrenia Bulletin, 18(3):437-448, 1992.
9. Bleuler, E. Dementia Praecox or the Group of Schizophrenias. (1911) Translated by J. Zinkin. New York, NY: International Universities Press, 1950.
10. Carpenter, W.T.J.; Heinrichs, D.W.; and Wagman, A.M.I. Deficit and nondeficit forms of schizophrenia: The concept. American Journal of Psychiatry, 145:578-583, 1988.
11. Censits, D.M.; Ragland, J.D.; Gur, R.C.; and Gur, R.E. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: A longitudinal study. Schizophrenia Research, 24:289-298, 1997.
12. Chouinard, G.; Jones, B.; Remington, G.; Bloom, D.; Addington, D.; MacEwan, G.W.; Labelle, A.; Beauclair, L.; and Arnott, W. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. Journal of Clinical Psychopharmacology, 13:25-40, 1993.
13. Delis, D.C.; Krarner, J.H.; Kaplan, E.; and Ober, B.A. California Verbal Learning Test, Research Edition. Cleveland, OH: Psychological Corporation, 1983.
14. Elvevåg, B., and Goldberg, T.E. Cognitive impairment in schizophrenia is the core of the disorder. Critical Reviews in Neurobiology, 14:1-21, 2000.
15. Fenton, W.S., and McGlashan, T.H. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. American Journal of Psychiatry, 151:351-356, 1994.
16. Goff, D.C., and Evins, A.E. Negative symptoms in schizophrenia: Neurobiological models and treatment response. Harvard Review of Psychiatry, 6:59-77, 1998.
17. Green, M.F.; Kern, R.S.; Braff, D.L.; and Mintz, J. Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the "right stuff"? Schizophrenia Bulletin, 26(1):119-136, 2000.
18. Green, M.F., and Nuechterlein, K.H. Should schizophrenia be treated as a neurocognitive disorder? Schizophrenia Bulletin, 25(2):309-319, 1999.
19. Heinrichs, R.W., and Zakzanis, K.K. Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology, 12:426-445, 1998.
20. Hoff, A.L.; Riordan, H.; O'Donnell, D.W.; Morris, L.; and DeLisi, L.E. Neuropsychological functioning of first-episode schizophreniform disorder. American Journal of Psychiatry, 149:898-903, 1992.
21. Hoff, A.L.; Sakuma, M.; Wieneke, M.; Horon, R.; Kushner, M.; and DeLisi, L.E. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. American Journal of Psychiatry, 156:1336-1341, 1999.
22. Hollingshead, A.B. Four-Factor Index of Social Status. New Haven, CT: Yale University, Department of Sociology, 1975.
23. Jastak, S., and Wilkinson, G.S. The Wide-Range Achievement Test - Revised Administration Manual. Rev. ed. Wilmington, DE: Jastak, 1984.
24. Kane, J.; Honigfeld, G.; Singer, J.; and Meltzer, H. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45:789-796, 1988.
25. Klove, H. Clinical neuropsychology. In: Foster, F.M., ed. The Medical Clinics of North America. New York, NY: Saunders, 1963. pp. 1647-1658.
26. Kraepelin, E. Dementia Praecox and Paraphrenia. (1919) Translated by R.M. Barclay. Huntington, NY: Robert E. Krieger, 1971.
27. Lieberman, J.A.; Alvir, J.M.J.; Woerner, M.G.; Degreef, G.; Bilder, R.M.; Ashtari, M.; Bogerts, B.; Mayerhoff, D.I.; Geisler, S.H.; Loebel, A.; Levy, D.L.; Hinrichsen, G.; Szymanski, S.; Chakos, M.; Koreen, A.; Borenstein, M.; and Kane, J.M. Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital. Schizophrenia Bulletin, 18(3):351-371, 1992.
28. McSweeney, A.J.; Naugle, R.I.; Chelune, G.J.; and Luders, H. "T scores for change": An illustration of a regression approach to depicting change in clinical neuropsychology. Clinical Neuropsychologist, 7:300-312, 1993.
29. Mohamed, S.; Paulsen, J.S.; O'Leary, D.; Arndt, S.; and Andreasen, N. Generalized cognitive deficits in schizophrenia: A study of first-episode patients. Archives of General Psychiatry, 56:749-754, 1999.
30. Overall, J.E., and Gorham, D.R. The Brief Psychiatric Rating Scale. Psychological Reports, 10:799-812, 1962.
31. Peralta, V.; Cuesta, M.J.; Martinez-Larrea, A.; and Serrano, J.F. Differentiating primary from secondary negative symptoms in schizophrenia: A study of neuroleptic-naive patients before and after treatment. American Journal of Psychiatry, 157:1461-1466, 2000.
32. Piper, W.E.; McCallum, M.; Joyce, A.S.; Azim, H.F.; and Ogrodniczuk, J.S. Follow-up findings for interpretative and supportive forms of psychotherapy and patient personality variables. Journal of Consulting and Clinical Psychology, 67:267-273, 1999.
33. Reitan, R.M., and Wolfson, D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, AZ: Neuropsychological Press, 1985.
34. Robinson, D.G.; Woemer, M.G.; Alvir, J.M.J.; Geisler, S.; Koreen, A.; Sheitman, B.; Chakos, M.; Mayerhoff, D.; Bilder, R.; Goldman, R.; and Lieberman, J.A. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. American Journal of Psychiatry, 156:544-549, 1999.
35. Rund, B.R., and Borg, N.E. Cognitive deficits and cognitive training in schizophrenic patients: A review. Acta Psychiatrica Scandinavica, 100:85-95, 1999.
36. Sawrie, S.M. Analysis of cognitive change: A commentary on Keith et al. (2002). Neuropsychology, 16:429-431, 2002.
37. Saykin, A.J.; Shtasel, D.L.; Gur, R.E.; Kester, D.B.; Mozley, L.H.; Stafiniak, P.; and Gur, R.C. Neuropsychological deficits in neuroleptic-naive patients with first-episode schizophrenia. Archives of General Psychiatry, 51:124-131, 1994.
38. Schuepbach, D.; Keshavan, M.S.; Kmiec, J.A.; and Sweeney, J.A. Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia. Schizophrenia Research, 53:249-261, 2002.
39. Scottish Schizophrenia Research Group. The Scottish First Episode Schizophrenia Study: II. Treatment: Pimozide versus flupenthixol. British Journal of Psychiatry, 150:334-338, 1987.
40. Seidman, L.J.; Pepple, J.R.; Faraone, S.V.; Kremen, W.S.; Green, A.I.; Brown, W.A.; and Tsuang, M.T. Neuropsychological performance in chronic schizophrenia in response to neuroleptic dose reduction. Biological Psychiatry, 33:575-584, 1993.
41. Spitzer, R.L.; Williams, J.B.; and Gibbon, M. Instruction Manual for the Structured Clinical Interview for DSM-III-R (SCID). New York, NY: Biometrics Research Department, New York State Psychiatric Institute, 1987.
42. Spitzer, R.L.; Williams, J.B.W.; and Gibbon, M. Structured Clinical Interview for DSM-IV: Patient Version (SCID-P). New York, NY: New York State Psychiatric Institute, 1994.
43. Sweeney, J.A.; Haas, G.L.; Keilp, J.G.; and Long, M. Evaluation of the stability of neuropsychological functioning after acute episodes of schizophrenia: One-year follow-up study. Psychiatry Research, 38:63-76, 1991.
44. Szymanski, S.R.; Cannon, T.D.; Gallacher, F.; Erwin, R.J.; and Gur, R.E. Course of treatment response in first-episode and chronic schizophrenia. American Journal of Psychiatry, 153:519-525, 1996.
45. Wechsler, D. Wechsler Adult Intelligence Scale - Revised. New York, NY: Psychological Corporation, 1981.
46. Wechsler, D. Wechsler Memory Scale - Revised. New York, NY: Psychological Corporation, 1987.